Natural Resistance Against Tumors “In Vivo”

  • Anna Maria Iorio
  • Franca Campanile
  • Mariela Neri
  • Abraham Goldin
  • Enzo Bonmassar


Host’s immunity against tumor cells can be classified according to two distinct functions, i.e. elicitable responses, evoked by tumor-associated antigens, and natural resistance (NR) not requiring previous exposure to antigenic determinants.


Lymphoma Cell Geometric Mean Hybrid Mouse BD2F1 Mouse Bone Marrow Graft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adam, D.O., and Snyderman, R., 1979, Do macrophages destroy nascent Tumors?, J. Natl. Cancer Inst., 62:1341.Google Scholar
  2. Bennett, M., 1972, Rejection of marrow allografts. Importance of H-2 homozygosity of donor cells, Transplantation, 14:289.PubMedCrossRefGoogle Scholar
  3. Bonmassar, A., Riccardi, C., Rivosecchi-Merletti, P., Goldin, A., and Bonmassar E., 1980, Transplantation resistance of drug--treated hybrid or allogeneic mice againsty murine lymphomas. I. Immuno-pharmacology studies, Int. J. Cancer, 26:819.PubMedCrossRefGoogle Scholar
  4. Bonmassar, A., Rivosecchi-Merleti, P., Barzi, A., Goldin, A., and Bonmassar, E., 1981, Transplantation resistance of drug-treated allogeneic mice against murine lymphomas. II. Studies with various tumor-host combinations, Int. J. Immunopharmac., 3, in press.Google Scholar
  5. Bonmassar, E., Cudkowicz, G., Vadlamudi, S., and Goldin, A., 1970, Influence of tumor-host differences at a single Histocompatibility Locus (H-1) on the antileukemic effect of 1,3-Bis (2-cloroethyl)-1-nitrosurea, Cancer Res., 30:2538.PubMedGoogle Scholar
  6. Bonmassar, E., Bonmassar, A., Goldin, A., and Cudkowicz, G., 1973, Depression of antilymphoma allograft reactivity by tumor-associated factors, Cancer Res., 33:1054.PubMedGoogle Scholar
  7. Bonmassar, E., Campanile, F., Houchens, D., Crino’, L., and Goldin, A., 1975, Impaired growth of a radiation-induced lymphoma in intact or lethally irradiated allogeneic athymic (nude) mice, Transplantation, 20:343.PubMedCrossRefGoogle Scholar
  8. Bonmassar, E., Campanile, F., Houchens, D., Goldin, A., and Herbermann, R.B., 1978, Growth inhibition of allogeneic lymphoma cells in lethally irradiated nude mice, in: “Proceeding of Symposium on the Use of Athymic (nude) mice in Cancer Research, Houchens, D., and Ovejera, A. eds., Gustav Fisher, New York, p. 73–80.Google Scholar
  9. Bonmassar, E., Riccardi, C., Campanile, F., Iorio, A.M., Puccetti, and P., Herberman, R.B., 1979, Radioresistant inhibition of tumors (RIT): biological and pharmacological studies, in: “Current Trends in Tumor Immunology,” S. Ferrone, S. Gorini, R.B. Herberman, R.A., and Reisfeld, eds., Garland Press, New York, p. 49.Google Scholar
  10. Campanile, F., and Bonmassar, E., 1980, Differential graft resistance of C3H mice pretreated with antitumor drugs against BALB/c bone marrow or lymphoma cells, J. of Immunopharmac., 2:527.CrossRefGoogle Scholar
  11. Campanile, F., Crino, L., Bonmassar, E., Houchens, D., and Goldin, A., 1977, Radioresistant inhibition of lymphoma growth in congenitally athymic (nude) mice, Cancer Res., 37:394.PubMedGoogle Scholar
  12. Carlson, G.A., and Wegman, T.G., 1977, Rapid “in vivo” destruction of semi-syngeneic and allogeneic cells by non immunized mice as a consequence of non identity at H-2, J. Immunol., 118:2130.PubMedGoogle Scholar
  13. Carlson, G.A., Melnychuk, D., and Meeker, M.J., 1980, H-2 associated resistance to leukemia transplantation natural killing “in vivo,” Int. J. Cancer, 25:111.PubMedCrossRefGoogle Scholar
  14. Clark, E.A., Harmon, R.C., and Wicker, L.S., 1977, Resistance of H-2 heterozygous mice to parental tumors. II. Characterization of Hh-1 controlled hybrid resistance to syngeneic fibrosarcomas and EL -4 lymphoma, J. Immunol., 119:648.PubMedGoogle Scholar
  15. Clark, R.A., and Klebanoff, S.J., 1975, Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system, J. Exp. Med., 141:1442.PubMedCrossRefGoogle Scholar
  16. Cudkowicz, G., 1968, Hybrid resistance to parental grafts on hematopoietic and lymphoma cells, in: “The Proliferation and Spread of Neoplastic Cell,” XXI Annual M.D. Anderson Symposium on Fundamental Cancer Research, Baltimore, Williams and Wilkins Co., p. 661.Google Scholar
  17. Cudkowicz, G., 1971, Genetic control of bone marrow graft rejection. I. Determinant specific difference of reacting in two pairs of inbred mouse strains, J. Exp. Med., 134:281.PubMedCrossRefGoogle Scholar
  18. Cudkowicz, G., 1975a, Genetic control of resistance to allogeneic and xenogeneic bone marrow grafts in mice, Transplant. Proc., 7:155.Google Scholar
  19. Cudkowicz, G., 1975b, Rejection of bone marrow allografts by irradiated athymic mice, Proc. Am. Assoc. Cancer Res., 16:170.Google Scholar
  20. Cudkowicz, G., and Bennett, M., 1971a, Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice, J. Exp. Med., 134:83.CrossRefGoogle Scholar
  21. Cudkowicz, G., and Bennett, M., 1971b, Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F1 hybrid mice, J. Exp. Med., 134:1513.CrossRefGoogle Scholar
  22. Cudkowicz, G., and Hochman, P.S., 1979, Do natural killer cells engaged in regulated reactions against self to ensure homeostasis?, Immunol. Rev., 44:13.PubMedCrossRefGoogle Scholar
  23. Cudkowicz, G., and Lotzova, E., 1973, Hemopoietic cell-defined components of the major histocompatibility complex of mice: identification of responsive and unresponsive recipients for bone marrow transplants, Transplant. Proc., 4:1399.Google Scholar
  24. Cudkowicz, G., and Rossi, G.B., 1972, Hybrid resistance to parental DBA/2 grafts: indipendence from H-2 locus. I. Studies with normal hematopoietic cells, J. Nat. Cancer Inst., 48:131.PubMedGoogle Scholar
  25. Cudkowicz, G., and Stimpfling, J.H., 1964, Deficient growth of C57B1 marrow cells transplanted in F1 hybrid mice. Association with the histocompatibility-2 locus, Immunology, 7:291.PubMedGoogle Scholar
  26. Cudkowicz, G., and Yung, Y.P., 1977, Abrogation of resistance to foreign bone marrow grafts by carrageenans. I. Studies with the antimacrophage agent seakem carrageenan, J. of Immunol., 119:483.Google Scholar
  27. Dawe, C.J., and Potter, M., 1957, Morphologic and biologic progression of a lymphoid neoplasm of the mouse “in vivo” and “in vitro”, Am. J. Pathol., 33:603.Google Scholar
  28. Dvorak, A.M., Connel, A.B., Proppe, K., and Dvorak, H.F., 1978, Immunologic rejection of mammary adenocarcinoma (TA3-St) in C57B1/6 mice: participation of neutrophiles and activated macrophages with fibrin formation, J. Immunol., 120:1240.PubMedGoogle Scholar
  29. Gallagher, M.T., Lotzova, E., and Trentin, J.J., 1976, Genetic resistance to marrow transplantation as a leukemia defence mechanism, in: “Immuno-aspects of the Spleen,” J.R. Battisto, J.W. Streilein eds., Elsevier-North-Holland Biomedical Press, Amsterdam, The Netherlands, p. 359.Google Scholar
  30. Giampietri, A., Bonmassar, E., and Goldin, A., 1978, Drug induced modulation of immune response in mice: effects of 5-(3,3′-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) and cyclophosphamide, J. of Lnmunopharmac., 1:61.CrossRefGoogle Scholar
  31. Glynn, J.P., Bianco, A.R., Goldin, and A., 1964, Studies on induced resistance against iso-transplants of virus induced leukemia, Cancer Res., 24:502.PubMedGoogle Scholar
  32. Gorer, P.A., 1950, Studies in antibody response of mice to tumor inoculation, Br. J. Cancer, 4:372.PubMedCrossRefGoogle Scholar
  33. Harmon, R.C., Clark, E.A., O’Toole, C., and Wicker, L.S., 1977, Resistance of H-2 heterozygous mice to parental tumors. I. Hybrid resistance and natural cytotoxicity to EL-4 are controlled by the H-2D Hh-1 region, Immunogenetics, 4:601.CrossRefGoogle Scholar
  34. Herberman, R.B., nd Holden, H.T., 1979, Natural killer cells as antitumor effector cells, J. Natl. Cancer Inst., 62:441.PubMedGoogle Scholar
  35. Herberman, R.B., Nunn, M.E., and Lavrin, B.H., 1975, Natural cytotoxic reactivity of mouse lymphoma cells against syngeneic and allogeneic tumors, I Distribution of reactivity and specificity, Int. J. Cancer, 16:216.PubMedCrossRefGoogle Scholar
  36. Herberman, R.B., Djeu, J.Y., Kay, H.D., Ortaldo, J.R., Riccardi, C., Bonnard, G.D., Holden, H.T., Fagnani, R., Santoni, A., and Puccetti, P., 1979, Natural killer cells: characteristics and regulation of activity, Immunol. Rev., 44:43.PubMedCrossRefGoogle Scholar
  37. Hibbs, J.B., 1976, The macrophage as tumoricidal effector cell: a review of “in vivo” and in vitro studies of the mechanism of the activated macrophage non-specific cytotoxic reaction, in: “The Macrophage in Neoplasia,” M.A. Fink, ed., Academic Press, New York, p. 83.Google Scholar
  38. Hofer, K.G., and Hughes, L., 1970, Incorporation of Iodo-deoxyuridine-125, into the DNA of L1210 leukemia cells during tumor development, Cancer Res., 30:236.Google Scholar
  39. Houchens, D., Iorio, A.M., Barzi, A., Goldin, A., and Bonmassar, E., 1975, Inhibition of antilymphoma allograft response in normal and lethally irradiated mice by cyclophosphamide (NSC-26271) and isophosphamide (NSC-109724), Cancer Chemioter. Rep., 59:967.Google Scholar
  40. Iorio, A.M., Barzi, A., Merletti, P., Goldin, A., and Bonmassar, E., 1976, A viral immunodepressive factor (IDF) associated with experimental mouse tumors, Cancer Res., 36:3851.PubMedGoogle Scholar
  41. Iorio, A.M., Campanile, F., Neri, M., Spreafico, F., Goldin, A., and Bonmassar, E., 1978, Inhibition of lymphoma growth in the spleen and liver of lethally irradiated mice, J. Immunol., 120:1679.PubMedGoogle Scholar
  42. Keller, R., 1976, Susceptibility of normal and transformed cell lines to cytostatic and cytocidal effects exerted by macrophages, J. Natl. Cancer Inst., 56:369.PubMedGoogle Scholar
  43. Keller, R., 1979, Suppression by radioactive strontium of the spontaneous cytotoxicity expressed by adherent, predominantly phagocitic cells, from various mouse tissues, Immunolology., 37:333.Google Scholar
  44. Keller, R., 1979, A consideration of the involvement of mononuclear phagocytes in tumor resistance, in: “Current trends in tumor immunology,” S. Ferrone, S. Gorini, R.B. Herberman, and R.A. Reisfeld, eds., Garland Press, New York, p. 121.Google Scholar
  45. Keller, R., 1980, Regulatory capacities of mononuclear phagocytes with particular reference to natural immunity against tumors, in: “Natural cell-mediated immunity against tumors,” R.B. Herberman ed., Accademic Press, New York, p. 1219.Google Scholar
  46. Kiessling, R., Hochman, P.S., Haller, O., Shearer, G.M., Wigzell, H., and Cudkowicz, G., 1977, Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts, Eur. J. Immunol., 7:655.PubMedCrossRefGoogle Scholar
  47. Klein, G.O., Klein, G., Kiessling, R., and Karre Klas, 1978, H-2 associated control of natural cytotoxicity and hybrid resistance against RBL-5 Immunogenetics, 6:561.Google Scholar
  48. Korec, S., Herberman, R.B., Dean, J.H., and Cannon, G.B., 1980, Cytostasis of tumor cell lines by human granulocytes, Cell. Immunol., 53:104.PubMedCrossRefGoogle Scholar
  49. Lohmann-Matthes, M.L., and Doxzig, W., 1979, Promonocytes have the functional characteristics of natural killer cells, J. Immunol., 123:1883.PubMedGoogle Scholar
  50. Lohmann-Matthes, M.L., and Domzig, W., 1980, Natural cytotoxicity of macrophage precursor cells and of mature macrophages, in: “Natural Cell-mediated Immunity against Tumors,” R.B. Herberman, ed., Academic Press, New York, p. 117.Google Scholar
  51. Lotzova, E., and Cudkowicz, G., 1974, Abrogation of resistance to bone marrow grafts by silica particles. Prevention of the silica effects by the macrophage stabilizer poly-2-vinylpyridine N-oxide, J. of Immunol., 113:798.Google Scholar
  52. McCoy, J.L., Fefer, A., and Glynn, J.P., 1967, Comparative studies on the induction of transplantation resistance in BALB/c and C57B1/6 mice in three murine leukemia systems, Cancer Res., 27:1743.PubMedGoogle Scholar
  53. Old, L.J., Boyse, E.A., and Stockert, E., 1965, The G (Gross) leukemia antigen, Cancer Res., 25:813.PubMedGoogle Scholar
  54. Puccetti, P., and Holden, H.T., 1979, Cytolitic and Cytostatic antitumor activities of macrophages from mice injected with murine sarcoma virus, Int. J. Cancer, 23:123.PubMedCrossRefGoogle Scholar
  55. Riccardi, C., Fioreti, M.C., Giampietri, A., Puccetti, P., Goldin, A., and Bonmassar, E., 1978, Growth inhibition of normal or drug-treated lymphoma cells in lethally irradiated mice, J. Natl. Cancer Inst., 60:1083.PubMedGoogle Scholar
  56. Riccardi, C., Puccetti, P., Santoni, A., and Herberman, R.B., 1979a, Rapid “in vivo” assay of mouse natural killer cell activity, J. Natl. Cancer. Inst., 63:1041.Google Scholar
  57. Riccardi, C., Puccetti, P., Santoni, A., Herberman, R.B., and Bonmassar, E., 1979b, Adriamycin-induced antitumor response in lethally irradiated mice, Immunopharmac., 1:211.CrossRefGoogle Scholar
  58. Riccardi, C., Santoni, A., Barlozzari, T., Puccetti, P., and Herberman, R.B., 1980, “In vivo” natural reactivity of mice against tumor cells, Int. J. Cancer, 25:475.PubMedCrossRefGoogle Scholar
  59. Roder, J.C., Karre, K., and Kiessling, R., 1981, Natural Killer cells, Prog. Allergy, 28:66.PubMedGoogle Scholar
  60. Schimitt-Verhulst, A.M., and Zatz, M.M., 1977, F1 Resistance to AKR lymphoma cells “in vivo” and “in vitro,” J. Immunol., 118:33.Google Scholar
  61. Stutman, O., Paige, C.G., and Feofigarella, E., 1978, Natural Cytotoxic cells against solid tumors in mice. I Strain and age distribution on target cell susceptibility, J. Immunol., 121:1819.PubMedGoogle Scholar
  62. Warner, N.L., Woodruff, M.F.A., and Burton, R.C., 1977, Inhibition of growth of lymphoid tumors in syngeneic athymic (nude) mice, Int. J. Cancer, 20:146.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Anna Maria Iorio
    • 1
  • Franca Campanile
    • 2
  • Mariela Neri
    • 1
  • Abraham Goldin
    • 3
  • Enzo Bonmassar
    • 2
  1. 1.Chair of VirologyUniversity of PerugiaPerugiaItaly
  2. 2.Institute of PharmacologyUniversity of PerugiaPerugiaItaly
  3. 3.National Cancer InstituteNational Institute of HealthBethesdaUSA

Personalised recommendations